Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development

Recent studies demonstrated that long noncoding RNAs (lncRNAs) have a critical role in the regulation of cancer progression and metastasis. However, little is known about the mechanism through which metastasis-associated lung adencarcinoma transcript 1 (MALAT1) exerts its oncogenic activity, and the interaction between MALAT1 and microRNA remains largely unknown. In the present study, we reported that MALAT1 was upregulated in triple-negative breast cancer (TNBC) tissues. Knockdown of MALAT1 inhibited proliferation, motility, and increased apoptosis in vitro. In vivo study indicated that knockdown of MALAT1 inhibited tumor growth and metastasis. Patients with high MALAT1 expression had poorer overall survival time than those with low MALAT1 expression. In addition, our findings demonstrate a reciprocal negative control relationship between MALAT1 and miR-1: downregulation of MALAT1 increased expression of microRNA-1 (miR-1), while overexpression of miR-1 decreased MALAT1 expression. Slug was identified as a direct target of miR-1. We proposed that MALAT1 exerted its function through the miR-1/slug axis. In summary, we proposed that MALAT1 may be a target for TNBC therapy.

[1]  Michael Thomas,et al.  MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer , 2003, Oncogene.

[2]  R. Shiekhattar,et al.  Human RISC Couples MicroRNA Biogenesis and Posttranscriptional Gene Silencing , 2005, Cell.

[3]  R. Plasterk,et al.  The diverse functions of microRNAs in animal development and disease. , 2006, Developmental cell.

[4]  J. Ansari,et al.  Chemotherapy for breast cancer (Review). , 2010, Oncology reports.

[5]  Frank Speleman,et al.  miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis , 2010, Nature Cell Biology.

[6]  Nicholas T. Ingolia,et al.  Mammalian microRNAs predominantly act to decrease target mRNA levels , 2010, Nature.

[7]  Randeep Rakwal,et al.  MALAT‐1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility‐related genes , 2010, FEBS letters.

[8]  C. Fan,et al.  Suppression of Breast Tumor Growth and Metastasis by an Engineered Transcription Factor , 2011, PloS one.

[9]  Jacqueline Cloos,et al.  Cell sensitivity assays: the MTT assay. , 2011, Methods in molecular biology.

[10]  D. Cacchiarelli,et al.  A Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNA , 2011, Cell.

[11]  T. Winder,et al.  Optimized allele-specific real-time PCR assays for the detection of common mutations in KRAS and BRAF. , 2011, The Journal of molecular diagnostics : JMD.

[12]  Martin Reczko,et al.  DIANA-LncBase: experimentally verified and computationally predicted microRNA targets on long non-coding RNAs , 2012, Nucleic Acids Res..

[13]  Yang Zhang,et al.  Increased expression of microRNA-335 predicts a favorable prognosis in primary gallbladder carcinoma , 2013, OncoTargets and therapy.

[14]  Zhiming Cai,et al.  Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder. , 2013, Urology.

[15]  Deeksha Bhartiya,et al.  Systematic Transcriptome Wide Analysis of lncRNA-miRNA Interactions , 2012, PloS one.

[16]  K. Chao,et al.  MicroRNA‐138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF‐1α , 2013, International journal of cancer.

[17]  D. Spector,et al.  The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. , 2013, Cancer research.

[18]  Guohua Wang,et al.  Potential roles of microRNAs in regulating long intergenic noncoding RNAs , 2013, BMC Medical Genomics.

[19]  Y. Kawasaki,et al.  The miR-1-NOTCH3-Asef Pathway Is Important for Colorectal Tumor Cell Migration , 2013, PloS one.

[20]  Hui Zhou,et al.  starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data , 2013, Nucleic Acids Res..

[21]  Hongtu Zheng,et al.  High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer. , 2014, International journal of clinical and experimental pathology.

[22]  Michael Y Tolstorukov,et al.  The long noncoding RNAs NEAT1 and MALAT1 bind active chromatin sites. , 2014, Molecular cell.

[23]  P. Pandolfi,et al.  The multilayered complexity of ceRNA crosstalk and competition , 2014, Nature.

[24]  N. Seki,et al.  Downregulation of the microRNA-1/133a cluster enhances cancer cell migration and invasion in lung-squamous cell carcinoma via regulation of Coronin1C , 2014, Journal of Human Genetics.

[25]  Liping Su,et al.  MALAT1 promotes cell proliferation in gastric cancer by recruiting SF2/ASF. , 2014, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[26]  J. Roa,et al.  miR-1 and miR-145 act as tumor suppressor microRNAs in gallbladder cancer. , 2014, International journal of clinical and experimental pathology.

[27]  Gwyn T. Williams,et al.  Regulation of apoptosis by long non-coding RNA GAS5 in breast cancer cells: implications for chemotherapy , 2014, Breast Cancer Research and Treatment.

[28]  Feipeng Zhao,et al.  EZH2 promotes angiogenesis through inhibition of miR-1/Endothelin-1 axis in nasopharyngeal carcinoma , 2014, Oncotarget.

[29]  Z. Du,et al.  Small molecules, big effects: the role of microRNAs in regulation of cardiomyocyte death , 2014, Cell Death and Disease.

[30]  Z. Jehan,et al.  Loss of PTEN expression is associated with aggressive behavior and poor prognosis in Middle Eastern triple-negative breast cancer , 2015, Breast Cancer Research and Treatment.

[31]  Xiaoping Liu,et al.  miR-26a suppresses tumour proliferation and metastasis by targeting metadherin in triple negative breast cancer. , 2015, Cancer letters.

[32]  Zicai Liang,et al.  Malat1 regulates serum response factor through miR‐133 as a competing endogenous RNA in myogenesis , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  Shao-Chun Wang,et al.  Combined inhibition of EGFR and c-ABL suppresses the growth of triple-negative breast cancer growth through inhibition of HOTAIR , 2015, Oncotarget.

[34]  Yong-He Hu,et al.  MicroRNA‐1 promotes apoptosis of hepatocarcinoma cells by targeting apoptosis inhibitor‐5 (API‐5) , 2015, FEBS letters.

[35]  P. Spanheimer,et al.  Receptor Tyrosine Kinase Expression Predicts Response to Sunitinib in Breast Cancer , 2015, Annals of Surgical Oncology.

[36]  Rajvir Dahiya,et al.  Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205. , 2015, Cancer research.

[37]  Qun Zhou,et al.  Genomics lincRNA-RoR and miR-145 Regulate Invasion in Triple-NegativeBreast Cancer via TargetingARF 6 , 2015 .

[38]  B. Tunca,et al.  BRCA mutations cause reduction in miR-200c expression in triple negative breast cancer. , 2015, Gene.